Correlation Between Vigil Neuroscience and Monte Rosa

Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vigil Neuroscience and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Vigil Neuroscience and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Monte Rosa.

Diversification Opportunities for Vigil Neuroscience and Monte Rosa

-0.25

Correlation Coefficient

Vigil Neuroscience  Monte Rosa

Very good diversification

The 3 months correlation between Vigil and Monte is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Monte Rosa go up and down completely randomly.

Pair Corralation between Vigil Neuroscience and Monte Rosa

Given the investment horizon of 90 days Vigil Neuroscience is expected to under-perform the Monte Rosa. But the stock apears to be less risky and, when comparing its historical volatility, Vigil Neuroscience is 2.45 times less risky than Monte Rosa. The stock trades about -0.08 of its potential returns per unit of risk. The Monte Rosa Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  563.00  in Monte Rosa Therapeutics on September 4, 2024 and sell it today you would earn a total of  459.00  from holding Monte Rosa Therapeutics or generate 81.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Vigil Neuroscience  vs.  Monte Rosa Therapeutics

Vigil Neuroscience

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Monte Rosa Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vigil Neuroscience and Monte Rosa

The main advantage of trading using opposite Vigil Neuroscience and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.

The idea behind Vigil Neuroscience and Monte Rosa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.